DNP-X acid

CAS No. 10466-72-5

DNP-X acid( 6-((2,4-Dinitrophenyl)amino)hexanoic acid )

Catalog No. M23257 CAS No. 10466-72-5

DNP-X acid is an amine-reactive building block and can be recognized by anti-DNP antibodies.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
50MG 36 In Stock
100MG 53 In Stock
200MG 77 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DNP-X acid
  • Note
    Research use only, not for human use.
  • Brief Description
    DNP-X acid is an amine-reactive building block and can be recognized by anti-DNP antibodies.
  • Description
    DNP-X acid is an amine-reactive building block and can be recognized by anti-DNP antibodies. It is also an excellent amine-reactive FRET quencher paired with Trp or Tyr.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    6-((2,4-Dinitrophenyl)amino)hexanoic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10466-72-5
  • Formula Weight
    297.26
  • Molecular Formula
    C12H15N3O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:45 mg/mL?(151.38 mM;?ultrasonic and warming and heat to 80°C)
  • SMILES
    [O-][N+](c(cc1)cc([N+]([O-])=O)c1NCCCCCC(O)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Monoethyl phthalate

    Monoethyl phthalate, a metabolite of diethyl phthalate, serves as a urinary biomarker for phthalate exposure and indicates potential risks of thyroid cancer and benign nodules.

  • 6,7-dimethylisatin

    6,7-Dimethylisatin (6,7-dimethyl-1H-indole-2,3-dione) inhibits hGAT3 with IC50 of 108 μM. 6,7-Dimethylisatin also inhibits hBGT1, hGAT2.

  • IKKγ NBD Inhibitory ...

    A cell-permeable synthetic peptide NEMO-binding domain peptide (NBD peptide) corresponding to the NEMO amino-terminal alpha-helical region is shown to block TNF-alpha-induced NF-kB activation. The interaction of IKγNEMO with the IKK complex is vital for the activation of the IKK complex and the subsequent activation of NF-kB.